Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Nymox reports results from U.S. NX-1207 study in benign prostatic hyperplasia

March 13, 2008

Genzyme launches Renvela in the U.S. for dialysis patients and submits MAA to the EMEA

March 7, 2008

New agents for treating urolithiasis disclosed in recent University of Western Ontario patent

March 7, 2008

New beta3 adrenoceptor agonists may be useful in overactive bladder

March 5, 2008

Biogen Idec and Cardiokine initiate a phase III study of lixivaptan

Feb. 18, 2008

New therapeutic agents for urinary incontinence imparted in recent Takeda patents

Feb. 18, 2008

Silodosin NDA accepted for filing by FDA for benign prostatic hyperplasia

Feb. 13, 2008

Plethora reports preliminary results from PSD-506 incontinence study

Feb. 8, 2008

Positive results reported from Nymox's U.S. study of NX-1207 for BPH

Feb. 7, 2008

New therapeutic agents for genitourinary disorders reported in recent Roche patent

Feb. 5, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...